findmyKOL

Omair Yousuf, MD

Basic profile

Bon Secours Heart & Vascular Institute

ORCIDNPI
RegionArlington, VA · SoutheastSpecialtyClinical Cardiac ElectrophysiologyFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Omair Yousuf is a Cardiology physician affiliated with Bon Secours Heart & Vascular Institute. OpenAlex indexes 46 publications with 1,388 citations (h-index 13).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
46publications

Distinct works indexed by OpenAlex, matched via ORCID.

1,388citations

Total citations across indexed works.

13h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
28companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1851 N George Mason Dr Ste 3c
Arlington, VA 222071953

Telephone

703-717-7780

Provider last certified this registry record 13 Aug 2025.

View the NPPES registry record

Industry payments

28 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    74.1%
    Antiarrhythmic15.1%
    Flecainide Acetate51%Amiodarone Hcl21%Dofetilide21%Multaq4%Pacerone4%
    Part D<11 patients
    Beta blocker13.8%
    Metoprolol Succinate71%Metoprolol Tartrate16%Carvedilol13%
    Part D61 patients

    + 12 more classes in this area

  • Blood & clotting

    18.6%
    Factor Xa inhibitor17.3%
    Eliquis73%Xarelto27%
    Part D72 patients
    P2Y12 inhibitor1.3%
    Clopidogrel100%
    Part D11 patients
  • Metabolism & gastrointestinal

    7.3%
    SGLT2 inhibitor3.2%
    Farxiga59%Jardiance41%
    Part D<11 patients
    Potassium supplement2.3%
    Potassium Chloride100%
    Part D11 patients

    + 1 more class in this area

Where care is delivered (Part B)12.2% facility · 87.8% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”